Skip to Main content Skip to Navigation
Journal articles

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy

Abstract : tumor angiogenesis, metastasis and growth following treatment with AM-neutralizing antibodies, AM receptor antagonists, or AM receptor interference. Anti-AM therapy is a promising strategy to be explored in oncology, not only as an anti-angiogenic alternative in the context of acquired resistance to VEGF treatment, but also as a potential antimetastatic approach.
Document type :
Journal articles
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-03105775
Contributor : l'Houcine Ouafik <>
Submitted on : Monday, January 11, 2021 - 12:41:34 PM
Last modification on : Tuesday, January 12, 2021 - 3:29:39 AM

File

Targeting Adrenomedullin in On...
Publisher files allowed on an open archive

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Ramiro Vázquez, Maria Riveiro, Caroline Berenguer-Daize, Anthony O’kane, Julie Gormley, et al.. Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy. Frontiers in Oncology, Frontiers, 2021, 10, ⟨10.3389/fonc.2020.589218⟩. ⟨hal-03105775⟩

Share

Metrics

Record views

83

Files downloads

52